Clinical Trial Optimization II
31 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Bud Whitmeyer
Scoop.it!

171-2012.pdf - Applying Business Analytics to Optimize Clinical Research Operation

Bud Whitmeyer's insight:

Nice paper by Dave Handelsman of SAS that outlines some of the promise that Clinical Trial Optimization can provide.

more...
No comment yet.
Scooped by Bud Whitmeyer
Scoop.it!

TransCelerate BioPharma Inc. Reveals Collaborative Methodology for Risk ... - State Journal

TransCelerate BioPharma Inc. Reveals Collaborative Methodology for Risk ... - State Journal | Clinical Trial Optimization II | Scoop.it
TransCelerate BioPharma Inc. Reveals Collaborative Methodology for Risk ...
State Journal
Information contained on this page is provided by an independent third-party content provider.
Bud Whitmeyer's insight:

Transcelerate BioPharma, a consortium of big pharmaceutical companies, is pursuing development of a Risk Based Monitoring (RBM) solution to allow for more intelligent monitoring of clinical trial sites.

 

Will Transcelerate become a technology supplier or just try to set standards for application of these types of technologies.

more...
No comment yet.
Scooped by Bud Whitmeyer
Scoop.it!

Xcellerate® Clinical Trial Optimization® at Covance

Xcellerate® Clinical Trial Optimization® at Covance | Clinical Trial Optimization II | Scoop.it
Endow Your Clinical Trials with the Benefits of Xcellerate, Covance’s unique approach to Clinical Trial Optimization
Bud Whitmeyer's insight:

Covance is applying intelligence to the task of patient enrollment in clinical trials.  This seems to be a good application of technology and use of Covance's significant amount of data but it seems a stretch to call this Clinical Trial Optimization.  Rather it would be better termed Patient Enrollment Optimization.

more...
No comment yet.
Rescooped by Bud Whitmeyer from Clinical Trials
Scoop.it!

Risk-based monitoring needed to boost clinical trial success - PharmaTimes

Risk-based monitoring needed to boost clinical trial success - PharmaTimes | Clinical Trial Optimization II | Scoop.it
Risk-based monitoring needed to boost clinical trial success PharmaTimes With another six companies getting on board last month, the consortium has now delivered the first major milestone among its five core clinical trial initiatives, which also...

Via Darshan
Bud Whitmeyer's insight:

Another perspective on Transcelerate's RBM initiative.

more...
No comment yet.